Press Releases from Nadrich & Cohen LLP (46 total)
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation.
Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed…
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots.
Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.…
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants.
Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems.
The two-day panel, which is expected…
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country.
Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the…
Bayer Agrees to Settlement in 70 Yaz Side Effects Lawsuits
Nadrich & Cohen, LLP reports that Bayer has agreed to settlements with a number of plaintiffs who sued the company over Yaz side effects.
Los Angeles, CA, March 5, 2012 – National law firm Nadrich & Cohen, LLP reports that Bayer Healthcare has agreed to settle approximately 70 lawsuits filed on behalf of women who claim they were seriously injured by Yaz birth control pills. The amount of the settlements has…
FDA Device Chief Calls for Stricter Regulation of Vaginal Mesh, Other Medical De …
Nadrich & Cohen, LLP reports that the FDA’s chief device regulator is calling for stricter governance of vaginal mesh and other medical devices.
Los Angeles, CA, March 2, 2012 – Nadrich & Cohen, LLP reports that the U.S. Food and Drug Administration’s top medical device regulator says the federal health agency needs more power to block the approval of unsafe medical devices.
According to a recent Bloomberg report, Jeffrey Shuren,…
Nadrich & Cohen, LLP Now Investigating Stevens Johnson Syndrome Cases Involving …
Nadrich & Cohen, LLP is now investigating cases of Stevens Johnson Syndrome caused by the prescription drug Lamictal.
Los Angeles, CA, March 1, 2012 – National law firm Nadrich & Cohen, LLP is pleased to announce that it is now investigating cases of Stevens Johnson Syndrome involving the prescription drug Lamictal.
Lamictal (lamotrigine) is commonly used to treat patients suffering from epileptic conditions and in some cases, it may also be…
U.K. Health Agency Issues Updated Guidelines for Metal Hip Recipients
Nadrich & Cohen, LLP reports that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has issued new health guidelines for patients with metal hip implants.
Los Angeles, CA, February 29, 2012 – National law firm Nadrich & Cohen, LLP reports on new health guidelines issued by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) regarding patients who received a metal hip implant, including those fitted with a DePuy…
Email Reveals DePuy Knew of ASR Hip Problems Before Recall Was Issued
Nadrich & Cohen, LLP reports on a recent email which suggests that Johnson & Johnson was aware of problems with its DePuy ASR hips for a year before the devices were ever recalled.
Los Angeles, CA, February 28, 2012 – Nadrich & Cohen, LLP, a national law firm specializing in representing plaintiffs injured by medical devices, has previously reported on the developments in the ongoing controversy surrounding the now-recalled DePuy…
Initial Hearing Scheduled in Federal Actos Bladder Cancer Litigation
Nadrich & Cohen, LLP reports that the federal judge presiding over the consolidated Actos bladder cancer cases has scheduled the first hearing in the pending litigation.
Los Angeles, CA, February 14, 2012 – Judge Rebecca Doherty issued an order on Monday announcing that she would be appointing lead counsel for the consolidated Actos lawsuits following a March 22nd status conference set to take place in Lafayette, LA. Judge Doherty was assigned…
Defective Metal Hips May Be Linked to Increased Cancer Risk
Nadrich & Cohen, LLP reports that a new British study suggests that patients with metal hip implants may be at an increased risk for developing cancer.
Los Angeles, CA, February 10, 2012 – Following a report last week that British metal hip implant recipients could be at risk of experiencing systemic toxicity, news has surfaced that researchers are investigating the link between these devices and cancer.
According to a report in…
Federal Vaginal Mesh Lawsuits to Be Consolidated in West Virginia District Court
A U.S. Judicial Panel has voted to consolidate three vaginal mesh multidistrict litigations into a single proceeding before a West Virginia district judge.
Los Angeles, CA, February 8, 2012 – The U.S. Judicial Panel on Multidistrict Litigation issued an order on Tuesday to consolidate three vaginal mesh multidistrict litigations (MDLs) into a single proceeding. The cases, which involve lawsuits filed against Boston Scientific, American Medical Systems and Johnson & Johnson’s…
W.R. Grace Offers $19.5M Settlement to Libby Asbestos Victims
Nadrich & Cohen, LLP reports that W.R. Grace has offered a $19.5M settlement to Montana residents who suffered asbestos-related complications.
Los Angeles, CA, February 3, 2012 – W.R. Grace has proposed a $19.5 million settlement to cover health care expenses for residents of Libby, Montana who suffered asbestos exposure caused by the company’s nearby vermiculite mine. The settlement funds would ensure that the Libby Medical Program, which was established in 2000…
GlaxoSmithKline Agrees to Settlement in 20,000 Avandia Lawsuits
Nadrich & Cohen, LLP reports that GlaxoSmithKline has agreed to settle approximately 20,000 Avandia side effects lawsuits.
Los Angeles, CA, February 3, 2012 – UK drug-maker GlaxoSmithKline has agreed to settle 20,000 Avandia side effects lawsuits. According to a Bloomberg report, the company previously agreed to pay at least $700 million to settle more than 15,000 claims on behalf of patients who said that the drug caused heart attacks, strokes…
Pfizer Seeking Consolidation of Zoloft Birth Defects Lawsuits
Nadrich & Cohen, LLP reports that Pfizer is seeking to consolidate a number of federal Zoloft birth defects lawsuits into a multidistrict litigation.
Los Angeles, CA, February 1, 2012 – Pfizer has reportedly asked a federal judicial panel to centralize a number of Zoloft birth defects lawsuits filed against the company. If the motion is granted, the cases would be consolidated for pretrial proceedings and heard in a federal district…
Nadrich & Cohen, LLP Joins DePuy Hip Litigation Consortium in Representing Victi …
Prominent national law firm Nadrich & Cohen, LLP is now assisting patients with injury claims involving metal-on-metal DePuy hip replacement devices.
Los Angeles, CA, January 31, 2012 – National law firm Nadrich & Cohen, LLP has joined the national DePuy hip injury lawyer’s consortium in representing patients who sustained injuries caused by the company’s metal hip implants. The firm’s DePuy group has filed over 100 DePuy ASR injury claims in states…
Bristol-Meyers Squibb Sued by 72 Plaintiffs Over Plavix Side Effects
Nadrick & Cohen, LLP reports that 72 plaintiffs have joined together in a Plavix side effects lawsuit filed against Bristol-Meyers Squibb.
Los Angeles, CA, January 27, 2012 – Seventy-two plaintiffs from across the country have joined together in filing a Plavix side effects lawsuit against the drug’s maker, Bristol-Meyers Squibb. According to the Madison Record, the plaintiffs are seeking an unspecified amount of compensation for injuries they say were caused…
Johnson & Johnson Reports Sales Up, Revenues Down Following DePuy Hip Recall
Nadrich & Cohen, LLP reports that Johnson & Johnson’s net earnings are down following the 2010 DePuy hip recall.
Los Angeles, CA, January 25, 2012 – The Johnson & Johnson Company reported that sales were up in the fourth quarter but revenues were sharply down, due largely in part to costs associated with litigation settlements and the 2010 DePuy metal hip recall.
The earnings announcement comes just a week after…
Nadrich & Cohen LLP Clarifies Statements Regarding Actos Bladder Cancer Lawsuits
Los Angeles, CA, January 24, 2012 – National law firm Nadrich & Cohen LLP would like to clarify previous statements regarding the pending Actos bladder cancer litigation.
Earlier press releases included incorrect information regarding the total number of Actos lawsuits filed against the drug’s manufacturer, Takeda Pharmaceuticals. Those releases, based on media reports, estimated the number of lawsuits filed in state and federal courts nationwide in connection with Actos numbered…
FDA Warns Multaq Users of Potential Health Risks
Nadrich & Cohen, LLP reports that the U.S. Food and Drug Administration has issued an updated safety warning for the heart medication Multaq.
Los Angeles, CA, January 24, 2012 – The U.S. Food and Drug Administration has issued an updated safety communication advising patients who use the heart medication Multaq (dronedarone) of the potential for serious complications.
The updated safety communication was issued on December 19, 2011 after an FDA safety…
FDA Warning Prompts DePuy Orthopaedics to Halt Sale of Custom Joint Replacements
Nadrich & Cohen, LLP reports that Johnson & Johnson’s DePuy Orthopaedics is halting the sale of certain custom joint replacements after receiving a warning from the U.S. Food and Drug Administration.
Los Angeles, CA, January 20, 2012 – Johnson & Johnson’s DePuy Orthopaedics says it will stop selling custom-fitted joint replacement devices after being warned by the U.S. Food and Drug Administration that the products were not in compliance with…
House Democrats Seek Congressional Hearings on Vaginal Mesh Safety
Nadrich & Cohen, LLP reports that some House Democrats are asking Republican members of the House Energy and Commerce Committee to hold inquiry hearings regarding the safety of certain vaginal mesh implants.
Los Angeles, CA, January 20, 2012 – Several House Democrats are asking Republican members of the House Energy and Commerce Committee to schedule a congressional hearing regarding the safety of transvaginal mesh devices manufactured by Johnson & Johnson…
Nadrich & Cohen, LLP Now Investigating Pradaxa Side Effects Claims in All 50 Sta …
National law firm Nadrich & Cohen, LLP is now offering free initial case evaluations to patients in all 50 states who suffered side effects caused by Pradaxa.
Los Angeles, CA, January 20, 2012 – Prominent national law firm Nadrich & Cohen, LLP is pleased to announce that the firm is now representing individuals who believe they were injured by Pradaxa, a blood thinner used to treat patients with a heart rhythm…
Nadrich & Cohen LLP Support's FDA-Mandated Vaginal Mesh Studies
The U.S. Food and Drug Administration has ordered transvaginal mesh implant manufacturers to conduct additional safety studies on these devices. Nadrich & Cohen LLP is currently offering free initial case evaluations to women in all 50 states who believe they were injured by a vaginal mesh implant.
Los Angeles, CA, January 13, 2012 – Nadrich & Cohen LLP is pleased to announce that it supports the Food and Drug Administration’s…
European Safety Review Supports Continued Sale of Actos, Despite Bladder Cancer …
The European Commission has concluded its safety review of Actos after concerns were raised about the drug’s link to bladder cancer. Nadrich & Cohen LLP is currently offering free initial case evaluations to concerned Actos users in all 50 states.
Los Angeles, CA, January 13, 2012 – Nadrich & Cohen LLP reports that the European Commission (EC) has completed its months-long safety review of Actos and concluded that the drug…
Status Conference Set in DePuy ASR Hip Multidistrict Litigation
A status conference in the pending DePuy ASR hip implant MDL has been scheduled for later this month. Nadrich & Cohen LLP is currently offering free case evaluations to patients in all 50 states who believe they were injured by a defective metal hip.
Los Angeles, CA, January 13, 2011 – Nadrich & Cohen LLP reports that a status conference has been scheduled for January 23, 2012 in the pending DePuy…
Federal Panel Votes to Consolidate Actos Bladder Cancer Lawsuits
Nadrich & Cohen LLP reports that a federal judicial panel has voted to consolidate pending Actos bladder cancer claims into a multidistrict litigation for pretrial proceedings.
Los Angeles, CA, January 5, 2012 – Plaintiffs in the Actos bladder cancer litigation have successfully moved to have the federal lawsuits consolidated into a multidistrict litigation for pretrial proceedings. The cases will be transferred to the Western District Court of Louisiana, with the…
Vaginal Mesh Devices Facing New Scrutiny from FDA
Nadrich & Cohen LLP reports that the U.S. Food and Drug Administration is ordering the makers of vaginal mesh implants to conduct additional research on the safety and efficacy of these devices.
Los Angeles, CA, January 6, 2012 – As the number of lawsuits filed in connection with defective vaginal mesh devices continues to escalate, the federal government is taking a closer look at the safety of the implants. The…
Nadrich & Cohen LLP Issues Updated Statement on DePuy Hip Implant Litigation
Nadrich & Cohen LLP is revising earlier statements made regarding the pending DePuy hip implant litigation.
Los Angeles, CA, January 6, 2012 -- Prominent national law firm Nadrich & Cohen LLP is issuing an updated statement regarding the pending DePuy ASR and DePuy Pinnacle hip implant litigation. A previous press release issued by the firm stated that both the ASR and Pinnacle hip systems had been recalled. The information contained…
More Actos Bladder Cancer Lawsuits Filed in Los Angeles
Nadrich & Cohen LLP reports that new lawsuits have been filed in Los Angeles against the maker of Actos by two patients who allege the drug caused bladder cancer.
Los Angeles, CA, December 30, 2011 – As Takeda Pharmaceuticals continues to battle litigation over its Type 2 diabetes drug Actos, three additional lawsuits were filed in a Los Angeles court. The newest claims join the thousands of other Actos lawsuits that…
Federal Vaginal Mesh Lawsuits Filed Against Boston Scientific
Nadrich & Cohen LLP reports that Boston Scientific is facing additional lawsuits in federal court filed by women who claim they were injured by the company’s vaginal mesh implants.
Los Angeles, CA, December 30, 2011 - Legal trouble continues to mount for medical device manufacturer Boston Scientific as additional lawsuits are filed in federal court by women who say they suffered serious injury after receiving one of the company’s transvaginal…
New Study Suggests Women Who Receive Vaginal Mesh Implants to Treat Pelvic Organ …
Nadrich & Cohen LLP reports that a new study suggests that women who receive vaginal mesh implants to treat stress incontinence need corrective surgery at a higher rate than women who are treated through other methods.
Los Angeles, CA, December 28, 2011 – A new study forthcoming in the January issue of the American Journal of Obstetrics and Gynecology found that women who are fitted with a vaginal mesh device…
Metal Hip Implant Failures Could Translate to Higher Taxes, Increased Health Car …
Nadrich & Cohen LLP reports that medical and legal experts are predicting that taxes, insurance costs and health care costs will skyrocket as more artificial hip implant devices fail.
Los Angeles, CA, December 28, 2011 – The report is based on a recent New York Times article, which profiled several individuals who received a metal-on-metal hip replacement system. One of the recipients profiled is currently facing nearly $500,000 in medical bills…
Actos Sales Predicted to Falter as Takeda Faces More Lawsuits
Nadrich & Cohen LLP reports that business analysts are predicting that Japanese drug-maker Takeda Pharmaceuticals will see a 50% drop in Actos sales as bladder cancer claims continue to mount.
Los Angeles, CA, December 26, 2011 – In 2010, Type 2 diabetes drug Actos generated approximately $4.8 billion in revenues for its manufacturer, Takeda Pharmaceuticals. According to a recent report from Bloomberg, the company will most likely see a loss…
New Study Questions Safety of Metal Hip Implants
Los Angeles, CA, December 26, 2011 – The makers of metal-on-metal hip implants may see a surge in injury lawsuits after a new study claims that the devices are less safe than their traditional counterparts. The study, which was sponsored by the U.S. Food and Drug Administration, is believed to be the most comprehensive body of research to date dedicated specifically to tracking failure rates among metal hip implant recipients.…
Online Case Evaluations Available for Women Injured by Vaginal Mesh
Women who have suffered serious complications after receiving a transvaginal mesh implant may now find free legal help online.
Los Angeles, CA, December 23, 2011 – In response to the growing number of lawsuits being filed against manufacturers of vaginal mesh devices, a prominent national law firm is now offering free online help to women who are concerned about potential side effects.
Vaginal mesh was first approved the U.S. Food…
Hip Implant Manufacturers Target of Congressional Probe
Nadrich & Cohen LLP reports that the federal government is attempting to implement new legislation that would require enhanced safety testing and tracking of hip implant devices.
Los Angeles, CA, December 23, 2011 – In response to growing concerns over the safety and efficacy of metal-on-metal hip implants, members of the U.S. Senate have proposed a new law which would require companies that manufacture these devices to conduct additional safety…
Takeda Pharmaceuticals, Eli Lilly Face Actos Class Action Lawsuit in Canada
Los Angeles, CA, December 22, 2011 – A class action lawsuit was filed in an Ontario Superior Court against Japanese drug-maker Takeda Pharmaceuticals, alleging that the company knew its popular Type 2 diabetes drug Actos causes bladder cancer. The class action suit also names Eli Lilly as a defendant.
According to court records, the lead plaintiff in the action is a Toronto woman who began taking Actos in 2002. The…
Wright Conserve Hip Implant Lawsuit Plaintiff Seeks Consolidation of Cases
Los Angeles, CA, December 22, 2011 – One of the plaintiffs who filed a personal injury lawsuit against Wright Medical Technologies Inc. over a faulty hip implant is asking a federal judge to consolidate the cases for pretrial proceedings. If the U.S. Panel on Multidistrict Litigation grants the motion, the cases will be heading to trial in the Northern or Southern District Court of Georgia.
Plaintiff Danny James claims that…
Vaginal Mesh Lawsuits Have Senate Seeking Increased Safety Measures
Los Angeles, CA, December 20, 2011 – Nadrich & Cohen LLP reports that the U.S. Senate has proposed a new piece of legislation aimed at reducing the number of consumers who suffer serious injuries caused by a defective medical device. The bill, which would require manufacturers to conduct ongoing safety studies of these devices after obtaining FDA approval, was drafted in part as a response to the growing number of…
Vaginal Mesh Lawsuits May Be Centralized in West Virginia Court
A number of plaintiffs who have filed lawsuits against the makers of vaginal mesh implants are seeking to consolidate the cases in a federal court. The push for consolidation comes as the first bellweather trials in the mesh litigation are scheduled to begin in November 2012.
The U.S. Panel on Multidistrict Litigation was presented with numerous motions to consolidate a number of cases filed against Johnson & Johnson, Boston Scientific and…
Despite Bladder Cancer Lawsuits, Generic Actos May Hit Market Next Year
Takeda Pharmaceuticals, the manufacturer of Type 2 diabetes drug Actos, may face stiff competition from generic competitors when the drug’s patent expires in August 2012. The Japanese drug-maker also faces trouble on another front in the form of thousands of lawsuits filed by Actos users who allege the drug caused them to develop bladder cancer.
Takeda has previously settled lawsuits from a number of drug manufacturers which would allow the…
Vaginal Mesh Resource Center Offers Help to Women Injured by a TVM Device
Los Angeles, CA, December 12, 2011 – As the manufacturers of transvaginal mesh implants face an increasing number of personal injury lawsuits, a new online resource center has been created to provide the latest news, updates and information on vaginal mesh to women have been injured by these devices.
Visitors to www.VaginalMeshLegalClaims.com can access a wealth of information regarding vaginal mesh implants, including the most recent FDA warnings on these…
Nadrich & Cohen Now Reviewing Actos Bladder Cancer Claims
Los Angeles, CA, December 12, 2011 – Nadrich & Cohen LLP, a prominent national law firm, is now reviewing claims from Actos users in all 50 states who developed bladder cancer after taking the drug. In an effort to connect with even more Actos users across the country, the firm has established an online resource center at www.SideEffectActos.com.
Actos was approved by the U.S. Food and Drug Administration to treat adults…
FDA Delays Actos Combo Drug Review as Actos Bladder Cancer Lawsuits Continue to …
Los Angeles, CA, December 9, 2011 – As Actos bladder cancer lawsuits continue to mount, the Food and Drug Administration has opted to delay its review of a new Type 2 diabetes drug that combines Actos with algoliptin. The FDA’s decision represents another blow to Japanese drug-maker Takeda Pharmaceuticals, who may face as many 10,000 lawsuits from Actos users who claim they developed bladder cancer after taking the drug.
The…
Women Injured by Vaginal Mesh Urged to Seek Legal help
Los Angeles, CA, December 7, 2011 - As vaginal mesh injury lawsuits continue to mount, the law firm of Nadrich & Cohen LLP is encouraging all women who’ve suffered complications after receiving a mesh implant to seek legal assistance. The firm has created www.VaginalMeshLegalClaims.com to provide information and resources for women across the country who have been injured by vaginal mesh.
To date, approximately 600 lawsuits have been filed against…
